Greg Fine, Co-chair of the Private Equity Practice, is well-versed in guiding funds and companies through middle market and mega deals in the technology, manufacturing, healthcare, life sciences, and energy sectors. He focuses on representing private equity funds, family offices and their portfolio companies in complex acquisitions, divestitures, recapitalizations, restructurings and “shared-control” deals. Greg brings a commercial, pragmatic and solutions-oriented perspective to his client’s transactions.
Prior to rejoining Mintz in 2012, Greg was an attorney at another Boston-based law firm. There, he represented private equity sponsors and publicly and privately held companies in corporate transactional matters.
Greg Fine, Co-chair of the Private Equity Practice, is well-versed in guiding funds and companies through middle market and mega deals in the technology, manufacturing, healthcare, life sciences, and energy sectors. He focuses on representing private equity funds, family offices and their portfolio companies in complex acquisitions, divestitures, recapitalizations, restructurings and “shared-control” deals. Greg brings a commercial, pragmatic and solutions-oriented perspective to his client’s transactions.
Experience
- Represented a fund in its $1.1 billion leveraged buyout of a construction manufacturer of bridge, drainage, earth stabilization, and stormwater solutions
- Represented a fund in its $223 million sale of a specialized large-scale bakery to another fund
- Represented a fund in its leveraged buyout of a global supplier of mobile audio/video accessories, installation and fabrication supplies, and OEM integration solutions
- Represented a fund in its leveraged buyout of a manufacturer of custom engineered protective covers, truck roll-up doors, and cable/hose carriers
- Represented a fund in its leveraged buyout of a manufacturer and fabricator of custom hose, conveyor belt, sealing/safety products with operations in the US and Canada
- Represented a fund in its sale of a cement, ready mix concrete, aggregate, asphalt production company to a large strategic acquirer
- Represented a health care-focused fund in its $130 million leveraged buyout of a wound company
- Represented a large fund in its $550 million sale of a large-scale dialysis company to another private equity company
- Represented a health care-focused private equity company in its $330 million leveraged buyout of two clinical medical laboratories
- Represented one of Europe’s leading independent music publishers in its $250 million acquisition of a well-renowned Broadway-based administrator and promoter of entertainment copyrights as well as the rights to the songs and musicals of certain legendary Broadway songwriters
- Represented a private equity company in its $23 million leveraged buyout of a restaurant chain
- Represented a private equity sponsor in the $70 million leveraged buyout of a hair care company
- Represented a portfolio company of a large private equity sponsor in the acquisition of a drug development company, with contingent consideration, based on success of the product, up to $400 million
viewpoints
Survival of Reps and Warranties: Survival of Reps and Warranties: Avoiding Unpleasant Surprises for Buyers
May 16, 2014 | Alert | By Gregory Fine, Jessica Mendoza
News & Press
Mintz’s Private Equity Practice Appoints New Leadership
November 17, 2022
Mintz Names New Leaders In Private Equity
November 17, 2022
Mintz Leads On A Quartet of Back-To-Back Private Equity Closings
October 25, 2022
Mintz Takes Lead For Med-Pharmex In Its Sale To Britain’s Dechra
August 31, 2022
Mintz Advised Capstone Partners in Sale to Huntington
March 01, 2022
Mintz Advises DW Healthcare Partners in Sale of Prime Education
August 29, 2018
The M&A Advisor Recognizes Mintz Transaction as $50 - 100 Million "Cross Border Deal of the Year"
June 05, 2018
Mintz Represents Right Networks in Sale of Controlling Interest to BV Investment Partners
October 11, 2016
Events & Speaking
Greg Fine, Co-chair of the Private Equity Practice, is well-versed in guiding funds and companies through middle market and mega deals in the technology, manufacturing, healthcare, life sciences, and energy sectors. He focuses on representing private equity funds, family offices and their portfolio companies in complex acquisitions, divestitures, recapitalizations, restructurings and “shared-control” deals. Greg brings a commercial, pragmatic and solutions-oriented perspective to his client’s transactions.
Recognition & Awards
- Senior editor of Boston College Law Review
- Order of the Coif
Recent Insights
